tradingkey.logo

J&J to discontinue E.coli vaccine candidate study

ReutersFeb 13, 2025 11:09 AM

- Johnson & Johnson JNJ.N on Thursday said it will discontinue a late-stage study of an experimental E.coli vaccine that it was developing in partnership with Sanofi SASY.PA.

The drugmaker said its decision was based on the recommendation of an independent committee that found the vaccine candidate may not be sufficiently effective.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI